Home/Filings/4/0000899243-23-005141
4//SEC Filing

Robinson John Edward 4

Accession 0000899243-23-005141

CIK 0001622229other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 3:52 PM ET

Size

9.6 KB

Accession

0000899243-23-005141

Insider Transaction Report

Form 4
Period: 2023-02-13
Robinson John Edward
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-13+160,000160,000 total
    Exercise: $13.63Exp: 2033-02-13Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]This stock option shall vest in equal monthly installments over a four year period.

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001856514

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 3:52 PM ET
Size
9.6 KB